Clinical profile and treatment response in patients with CASPR2 antibody-associated neurological disease

Conclusion: CASPR2 antibody-associated disease has favorable response to immunotherapy with complete improvement and good outcome. Underlying malignancy may be a marker for poor prognosis.

Source: Annals of Indian Academy of Neurology - April 28, 2021 Category: Neurology Authors: Sumanth Shivaram Madhu Nagappa Doniparthi V Seshagiri Anita Mahadevan Yashwanth Gangadhar TN Sathyaprabha Vijay Kumavat Rose D Bharath Sanjib Sinha Arun B Taly Source Type: research